Elequin Capital’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Elequin Capital’s Portfolio LSBPW Stock Details LSBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-37,500	Closed	-$1.43K	–	498
2023 Q4	$1.43K	Hold	37,500	–	–	﹤0.01%	298
2023 Q3	$1.54K	Hold	37,500	–	–	﹤0.01%	315
2023 Q2	$1.76K	Hold	37,500	–	–	﹤0.01%	452
2023 Q1	$5.84K	Buy	+37,500	New	+$5.68K	﹤0.01%	208

Other funds holding LSBPW

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

VAM

Valliance Asset Management Central, Hong Kong $122M AUM 362.1% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

BFAM Partners Northpoint, Hong Kong, Hong Kong $44K AUM 8.69% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

BCL

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

QGA

Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

Elequin Capital's LSBPW Position: Q1 2024 in Review

Elequin Capital sold out of LakeShore Biopharma Warrants (LSBPW) in Q1 2024, closing a stake of 37,500 shares — an estimated $1.43K sold.

Elequin Capital first reported a position in LSBPW in Q1 2023 and held it in 4 quarters. The position peaked at $5.84K in Q1 2023. 25 funds tracked by Wall St. Rank hold LSBPW as of Q1 2024.

Elequin Capital reported no remaining LakeShore Biopharma Warrants position as of Q1 2024 after selling out during the quarter.
Elequin Capital sold 37,500 LakeShore Biopharma Warrants shares in Q1 2024, an estimated $1.43K.
Elequin Capital first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 4 quarters.
Elequin Capital's LakeShore Biopharma Warrants position peaked at $5.84K in Q1 2023.
25 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q1 2024.

Based on Elequin Capital's 13F filing for Q1 2024, filed 15 May 2024.